Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Adult Patients
.
Show all posts
Showing posts with label
Adult Patients
.
Show all posts
Friday, March 1, 2024
FDA Approves Jaypirca (pirtobrutinib) for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma
›
Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), announced the U.S. Food and Drug Administration (FDA) approved Jaypirc...
Thursday, March 10, 2022
FDA Approves Recorlev (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome
›
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), announce the U.S. Food and Drug Administration (FDA) approval of Recorlev ® (levoketoconazo...
Monday, February 17, 2020
FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients
›
In continuation of my update on lemborexant Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) today announced that...
›
Home
View web version